As people age, a buildup of calcium on the aortic valve can make it thicker and stiffer leading to aortic stenosis.

The phase II data are promising for patients who are managed with watchful waiting before being offered an intervention.

Fibrosis predicts post-surgical risk in aortic stenosis, reinforcing its role in guiding treatment decisions for both sexes.

An experimental drug originally developed by Sanofi that is now being advanced by the Mayo Clinic significantly curbed ...

a buildup of calcium on the aortic valve can make it thicker and stiffer leading to aortic stenosis. In addition, congenital heart defects, rheumatic fever, bacterial infections of the heart ...

Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.

St. Luke’s University Health Network has become the first in the Lehigh Valley to use a new, non-invasive diagnostic option ...

In patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) with stable coronary ...

Due to the significant increase in afterload in patients with aortic stenosis, left ventricular remodeling and fibrosis occur, which impair microcirculatory function. Our study results indicate that ...

This study aimed to confirm the prognostic value of a novel angiographic microvascular resistance (AMR) index in patients undergoing transcatheter aortic valve replacement.

If you need assistance, call the newsroom at 203-784-8801.